CDIPT blocking peptide product blog
Tags: Blocking Peptide; Cdipt; CDIPT blocking peptide;
The CDIPT cdipt (Catalog #MBS9227988) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The CDIPT cdipt product has the following accession number(s) (GI #3914340) (NCBI Accession #O14735.1) (Uniprot Accession #O14735). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Catalyzes the biosynthesis of phosphatidylinositol (PtdIns) as well as PtdIns:inositol exchange reaction. May thus act to reduce an excessive cellular PtdIns content. The exchange activity is due to the reverse reaction of PtdIns synthase and is dependent on CMP, which is tightly bound to the enzyme.
Cellular Location: Endoplasmic reticulum membrane; Multi-pass membrane protein. Golgi apparatus membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein. Membrane. Tissue Location: Detected in placenta (at protein level). Widely expressed. Higher expression in adult liver and skeletal muscle, slightly lower levels seen in pancreas, kidney, lung, placenta, brain, heart, leukocyte, colon, small intestine, ovary, testis, prostate, thymus and spleen. In fetus, expressed in kidney, liver, lung and brain. Blood, Brain, Eye, Heart, Kidney, Liver, Lung, Muscle, Nerve, Pancreas tissues are correlated with this protein. The following patways have been known to be associated with this gene. Brain Diseases, Carcinoma, Hepatocellular, Cell Transformation, Neoplastic, Disease Models, Animal, Fatty Liver, Inflammation, Liver Diseases, Lung Neoplasms, Neoplasms, Experimental, Nervous System Diseases are some of the diseases may be linked to CDIPT Antibody (Center) Blocking Peptide.